The discovery of SKLB-0335 as a paralog-selective EZH2 covalent inhibitor

Qiangsheng Zhang1, Xi Hu, Lu Li

  • 1State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan 610041, P. R. China. liuzhihao@scu.edu.cn yuluot@scu.edu.cn.

Chemical Communications (Cambridge, England)
|February 24, 2021
PubMed